| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | Sep 19, 2025 | Y-mAbs Therapeutics, Inc. | Director | Sell | 42.5 | -30,905 | -100.00% | ✗ | $50.1K |
| Aug 7, 2025 | Aug 11, 2025 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,702 | 32.54% | ✗ | $200.8K |
| May 8, 2019 | May 10, 2019 | GILEAD SCIENCES, INC. | EVP, Worldwide Commercial Ops | Sell | 95.0 | +6,340 | 100.00% | ✗ | $231.2K |